Muscle-specific inositide phosphatase (MIP/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis

Aging

Volumn 2, Issue 8, 2010, Pages 504-513

  Romero Suarez, Sandra ^a   Shen, Jinhua ^b   Brotto, Leticia ^a   Hall, Todd ^a   Mo, ChengLin ^a   Valdivia, Héctor H ^c   Andresen, Jon ^a,d   Wacker, Michael ^a,d   Nosek, Thomas M ^b   Qu, Cheng Kui ^b   Brotto, Marco ^a,d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intracellular calcium homeostasis; MIP MTMR14; Muscle aging; Sarcopenia; Skeletal muscle

Indexed keywords

1 STEAROYL 2 ARACHIDONOYL PHOSPHATIDYLINOSITOL; 1-STEAROYL-2-ARACHIDONOYL PHOSPHATIDYLINOSITOL; CALCIUM; MTMR14 PROTEIN, HUMAN; MTMR14 PROTEIN, MOUSE; PHOSPHATASE; PHOSPHATIDYLINOSITOL;

AGING; ANIMAL; ARTICLE; CELL AGING; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; MUSCLE ATROPHY; MUTATION; MYOPATHY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SKELETAL MUSCLE;

AGING; ANIMALS; CALCIUM; CELL AGING; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; PHENOTYPE; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES; SARCOPENIA;

EID: 79952202632     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100190     Document Type: Article

References (41)

1. Faulkner JA, Brooks SV, Zerba E. Muscle atrophy and weakness with aging: Contration-induced injury as an underlying mechanism. J Gerontol. 1995; 50A:124-129.
2. Gonzalez E, Messi ML, Delbono O. The Specific Force of Single Intact Extensor Digitorum Longus and Soleus Mouse Muscle Fibers Declines with Aging. J Membr Biol. 2000; 178:175-183.
3. Faulkner JA, Brooks SV, Zerba E. Muscle atrophy and weakness with aging: contraction-induced injury as an underlying mechanism. J Gerontol A Biol Sci Med Sci. 1995; 50 Spec No:124-129.
4. Delbono O. Molecular mechanisms and therapeutics of the deficit in specific force in ageing skeletal muscle. Biogerontology. 2005; 3:265-270.
5. Zahn JM, Sonu R, Vogel H, Crane E, Mazan-Mamczarz K, Rabkin R, Davis RW, Becker KG, Owen AB, Kim SK. Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet. 2006; 2:e115.
6. Bouchard C, Shephard RJ, Stephens T, Sutton JR, McPherson BD. Exercise, fitness, and health: A consensus statement. In: Bouchard C, Shephard RJ, Stephens T, Sutton JR, McPherson BD (eds.) Exercise, Fitness, and Health: A Consensus of Current Knowledge. 1990; Human Kinetics Books, Champaign, pp. 3-28.
7. Bortz WM. How fast do we age? Exercise performance over time as a biomarker. J Gerontol A Biol Sci Med Sci. 1996; 51:M223-M225.
8. Lowe DA, Husom AD, Ferrington DA, Thompson LV. Myofibrillar myosin ATPase activity in hindlimb muscles from young and aged rats. Mech Ageing Dev. 2004; 125:619-627.
9. Lowe DA, Thomas DD, Thompson LV. Force generation, but not myosin ATPase activity, declines with age in rat muscle fibers. Am J Physiol Cell Physiol. 2002; 283:C187-C192.
10. 2+ entry in muscle physioloy. Current Chemical Biology. 2007; 1:87-95.
11. Zhao X, Weisleder N, Thornton A, Oppong Y, Campbell R, Ma J, Brotto M. Compromised store-operated Ca(2+) entry in aged skeletal muscle. Aging Cell. 2008;7:561-568.
12. Brum G, Rios E, Stefani E. Effects of extracellular calcium on calcium movements of excitation-contraction coupling in frog skeletal muscle fibres. J Physiol. 1998; 398:441-73.:441-473.
13. Doran P, Donoghue P, O'Connell K, Gannon J, Ohlendieck K. Proteomics of skeletal muscle aging. Proteomics. 2009; 9:989- 1003.
14. Gannon J, Staunton L, O'Connell K, Doran P, Ohlendieck K. Phosphoproteomic analysis of aged skeletal muscle. Int J Mol Med. 2008; 22:33-42.
15. O'Connell K, Gannon J, Doran P, Ohlendieck K. Proteomic profiling reveals a severely perturbed protein expression pattern in aged skeletal muscle. Int J Mol Med. 2007; 20:145-153.
16. Shen J, Yu WM, Brotto M, Scherman JA, Guo C, Stoddard CJ, Yu WM, Brotto M, Scherman JA, Guo C, Stoddard C, Nosek TM, Valdivia HH, Qu CK. Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol. 2009; 11:769-776.
17. Fowler SC, Zarcone TJ, Chen R, Taylor MD, Wright DE. Low grip strength, impaired tongue force and hyperactivity induced by overexpression of neurotrophin-3 in mouse skeletal muscle. Int J Dev Neurosci. 2002; 20:303-308.
18. Zhao X, Yoshida M, Brotto L, Takeshima H, Weisleder N, Hirata Y, Nosek TM, Ma J, Brotto M. Enhanced resistance to fatigue and altered calcium handling properties of sarcalumenin knockout mice. Physiol Genomics. 2005; 23:72-78.
19. Sudhahar CG, Haney RM, Xue Y, Stahelin RV. Cellular membranes and lipid-binding domains as attractive targets for drug development. Curr Drug Targets. 2008; 9:603-613.
20. Eaton S. Multiple roles for lipids in the Hedgehog signalling pathway. Nat Rev Mol Cell Biol. 2008; 9:437-445.
21. Rivera R, Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol. 2008; 160:25-46.:25-46.
22. Deigner HP, Hermetter A. Oxidized phospholipids: emerging lipid mediators in pathophysiology. Curr Opin Lipidol. 2008; 19:289-294.
23. Sagin FG, Sozmen EY. Lipids as key players in Alzheimer disease: alterations in metabolism and genetics. Curr Alzheimer Res. 2008; 5:4-14.
24. Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol; 2008; 3:279- 312.:279-312.
25. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008; 9:139- 150.
26. Muoio DM, Koves TR. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab. 2007; 32:874-883.
27. Sang N, Chen C. Lipid signaling and synaptic plasticity. Neuroscientist. 2006; 12:425-434.
28. Balla T. Phosphoinositide-derived messengers in endocrine signaling. J Endocrinol. 2006; 188:135-153.
29. Krauss M, Haucke V. Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling. EMBO Rep. 2007; 8:241-246.
30. Krauss M, Haucke V. Phosphoinositides: regulators of membrane traffic and protein function. FEBS Lett. 2007; 581:2105-2111.
31. Robinson FL, Dixon JE. Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 2006; 16:403-412.
32. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene. 2008; 27:5443-5453.
33. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, Klauck SM, Poustka A, Dahl N. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996; 13:175-182.
34. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet. 2000; 25:17-19.
35. Azzedine H, Bolino A, Taieb T, Birouk N, Di DM, Bouhouche A, Benamou S, Mrabet A, Hammadouche T, Chkili T, Gouider R, Ravazzolo R, Brice A, Laporte J, LeGuern E. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with earlyonset glaucoma. Am J Hum Genet. 2003; 72:1141-1153.
36. Senderek J, Bergmann C, Weber S, Ketelsen UP, Schorle H, Rudnik-Schoneborn S, Buttner R, Buchheim E, Zerres K. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet; 2003; 12:349-356.
37. Brotto MA, Nosek TM, Kolbeck RC. Influence of ageing on the fatigability of isolated mouse skeletal muscles from mature and aged mice. Exp Physiol. 2002; 87:77-82.
38. Nosek TM, Brotto MA, Essig DA, Mestril R, Conover RC, Dillmann WH, Kolbeck RC. Functional properties of skeletal muscle from transgenic animals with upregulated heat shock protein 70. Physiol Genomics. 2000; 4:25-33.
39. Weisleder N, Brotto M, Komazaki S, Pan Z, Zhao X, Nosek T, Parness J, Takeshima H, Ma J. Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J Cell Biol. 2006; 174:639-645.
40. Kolbeck RC, Spear WA. Diaphragm contactility as related to cellular calcium metabolism: Influence of theophylline and fatigue.1989; 139 ed., p. 495.
41. 2+ channels and the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 1996; 270:H518- H525.